Experience with hemodialysis and renal transplantation in patients with malignant hypertension.
D058186:Acute Kidney Injury / Q000209:etiology; D000328:Adult; D001927:Brain Diseases / Q000209:etiology; D003981:Diazoxide / Q000627:therapeutic use; D004035:Diet Therapy; D005260:Female; D005500:Follow-Up Studies; D005665:Furosemide / Q000627:therapeutic use; D006084:Graft Rejection; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D008914:Minoxidil / Q000627:therapeutic use; D009392:Nephrectomy; D011433:Propranolol / Q000627:therapeutic use; D006435:Renal Dialysis; D012964:Sodium; D014184:Transplantation, Homologous; D014462:Ultrafiltration; D014511:Uremia / Q000209:etiology
D006830:Hydralazine; D008750:Methyldopa; D008914:Minoxidil; D005665:Furosemide; D012964:Sodium; D011433:Propranolol; D003981:Diazoxide